LLY - in preparation for strong earnings report!Moving on to our next great Stock set up - LLY
Eli Lilly and Company (LLY) has demonstrated robust financial performance, driven by its innovative pharmaceutical offerings, particularly in the weight-loss segment.
In the third quarter of 2024, the company reported a 20% year-over-year increase in